Clinical use of growth factors in chronic renal failure
- PMID: 10654818
- DOI: 10.1097/00041552-200001000-00002
Clinical use of growth factors in chronic renal failure
Abstract
Erythropoietin has been demonstrated to improve the quality of life in patients with chronic renal failure, and growth hormone has been approved for use in children with chronic renal failure and short stature as a growth promoting agent. Growth factors also have great therapeutic potential to improve glomerular function in the setting of chronic renal failure. Further studies are required to delineate the role of insulin-like growth factor I in the setting of end-stage chronic renal failure.
Comment in
-
Insulin-like growth factor I treatment for end-stage renal disease at the end of the millennium.Curr Opin Nephrol Hypertens. 2000 Jan;9(1):1-3. doi: 10.1097/00041552-200001000-00001. Curr Opin Nephrol Hypertens. 2000. PMID: 10654817 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
